ADAFLEX®(Immediate release melatonin tablet)

Clinical Indication

Sleep disorders in children (see comments). Continued in adults if proven efficacy in childhood

Comments

Doses of 10mg or less. See LLR APC melatonin guide for children for place in therapy and additional information

Date of classification

July 2022

Yellow

Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.